Edit Entry | Edit CV

Surachai Supattapone, MD, PhD

Title(s)
Professor of Biochemistry and Cell Biology
Professor of Medicine

Department(s)
Biochemistry and Cell Biology
Medicine

Education
Johns Hopkins University School of Medicine, Ph.D. 1992
Johns Hopkins University School of Medicine, M.D. 1992, Oxford University D.Phil. 1991

Programs
Molecular and Cellular Biology Graduate Programs
Molecular Pathogenesis Program
Neuroscience Center at Dartmouth

Websites
http://dms.dartmouth.edu/supattapone/
http://dms.dartmouth.edu/ncd/
http://dms.dartmouth.edu/mcb/faculty/supattapone.php
http://www.dartmouth.edu/~m2p2/colleagues/faculty.html#supattapone

Academic Analytics
View Profile

Contact Information

Dartmouth Medical School
74 College Street
Vail Building Room 311
Hanover NH 03755

Office: 603-646-5212
Phone: 603-646-5213
Email: supattapone@dartmouth.edu


Professional Interests

Prion Diseases
Neurodegeneration
Protein Misfolding
Genome-wide CRISPR screens

Biography

Surachai joined the Dartmouth faculty in 2001, and has enjoyed teaching in the Year One Metabolism and Scientific Basis of Medicine courses for medical students, as well as the Core Course for Molecular and Cellular Biology graduate students. He has also greatly enjoyed having the opportunity to mentor students conducting laboratory research projects on the pathogenesis of prion disease. Surachai has also served as the Chair for the Molecular and Cellular Biology (MCB) Graduate Program, the director for the Clinical Translational Science Masters Program, a director for the Cellular and Molecular Basis of Disease course, and member of the Medical Education Committee and the Committee for Student Performance and Conduct. He has also served as a standing member of two NIH study sections. He has won teaching awards at Geisel and at the University of California at San Francisco, and been elected as a Fellow to both the American Society for Microbiology (ASM) and the American Association for the Advancement of Science (AAAS).


Selected Publications

 

Anti-prion drugs do not improve survival in novel knock-in models of inherited prion disease.
Walsh DJ, Rees JR, Mehra S, Bourkas MEC, Kaczmarczyk L, Stuart E, Jackson WS, Watts JC, Supattapone S
PLoS Pathog. 2024 Apr;20(4):e1012087. doi: 10.1371/journal.ppat.1012087. Epub 2024 Apr 1.
PMID: 38557815

Correction: Emergence of Prions Selectively Resistant to Combination Drug Therapy.
Burke CM, Mark KMK, Kun J, Beauchemin KS, Supattapone S
PLoS Pathog. 2024 Jan;20(1):e1011919. doi: 10.1371/journal.ppat.1011919. Epub 2024 Jan 8.
PMID: 38190351

Anti-prion drugs do not improve survival in knock-in models of inherited prion disease.
Walsh DJ, Rees JR, Mehra S, Bourkas MEC, Kaczmarczyk L, Stuart E, Jackson WS, Watts JC, Supattapone S
bioRxiv. 2023 Sep 29; pii: 2023.09.28.559951. doi: 10.1101/2023.09.28.559951. Epub 2023 Sep 29.
PMID: 37808761

Cancer Epidemiology in the Northeastern United States (2013-2017).
Rees JR, Weiss JE, Gunn CM, Carlos HA, Dragnev NC, Supattapone EY, Tosteson ANA, Kraft SA, Vahdat LT, Peacock JL
Cancer Res Commun. 2023 Aug;3(8):1538-1550. doi: 10.1158/2767-9764.CRC-23-0152. Epub 2023 Aug 14.
PMID: 37583435

Phospholipid cofactor solubilization inhibits formation of native prions.
Schwind AM, Walsh DJ, Burke CM, Supattapone S
J Neurochem. 2023 Sep;166(5):875-884. doi: 10.1111/jnc.15930. Epub 2023 Aug 7.
PMID: 37551010

Conformational diversity in purified prions produced in vitro.
Walsh DJ, Schwind AM, Noble GP, Supattapone S
PLoS Pathog. 2023 Jan;19(1):e1011083. doi: 10.1371/journal.ppat.1011083. Epub 2023 Jan 10.
PMID: 36626391

A single protective polymorphism in the prion protein blocks cross-species prion replication in cultured cells.
Arshad H, Patel Z, Amano G, Li LY, Al-Azzawi ZAM, Supattapone S, Schmitt-Ulms G, Watts JC
J Neurochem. 2023 Apr;165(2):230-245. doi: 10.1111/jnc.15739. Epub 2022 Dec 24.
PMID: 36511154

Hydrogen Peroxide-induced Cell Death in Mammalian Cells.
Chidawanyika T, Supattapone S
J Cell Signal. 2021;2(3):206-211. doi: 10.33696/signaling.2.052.
PMID: 35079745

Alternating anti-prion regimens reduce combination drug resistance but do not further extend survival in scrapie-infected mice.
Beauchemin KS, Rees JR, Supattapone S
J Gen Virol. 2021 Dec;102(12) doi: 10.1099/jgv.0.001705.
PMID: 34904943

SEC24A facilitates colocalization and Ca(2)(+) flux between the endoplasmic reticulum and mitochondria.
Chidawanyika T, Chakrabarti R, Beauchemin KS, Higgs HN, Supattapone S
J Cell Sci. 2021 Mar 26;134(6) doi: 10.1242/jcs.249276. Epub 2021 Mar 26.
PMID: 33622772

View more publications on PubMed